Busse Convenience Kits Recalled Due to Manufacturing Test Validation Issue
Busse Hospital Disposables is recalling Busse Convenience kits containing swab/swabstick drug products due to uncertainty about the adequacy of manufacturing test method validation.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II designation indicates regulatory concern beyond minor defects. The issue involves uncertainty about the adequacy of manufacturing test method validation for drug products, representing a potential risk of harm. No illnesses or injuries have been reported.
Plain-English summary
Busse Hospital Disposables, Inc. is recalling Busse Convenience kits containing swab/swabstick drug products manufactured by Professional Disposables International (PDI). The recall affects 300 units distributed nationwide.
The affected product lot numbers are 2030982, 2031072, 2130198, 2130352, 2130706, and 2130876 (UDI: 00849233002227).
The recall was issued due to uncertainty regarding the adequacy of the validation of the test methods used to manufacture the drug products. This raises concerns that the manufacturing test methods may not have been sufficiently validated to ensure product quality and safety.
The recalled product
- Product
- SS 3.2MM Pellet Insertion Tray Catalog Number: B8110R1
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug
- Hazard
- inadequate-testing
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27